Institutional Career Development
机构职业发展
基本信息
- 批准号:10053473
- 负责人:
- 金额:$ 44.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-12 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAreaAwardAwarenessBuffaloesClinicalClinical InvestigatorClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesCompetenceComplementDisciplineDiseaseDoctor of PharmacyDoctor of PhilosophyDocumentationEducational CurriculumEvaluationFacultyFundingGoalsHealth SciencesIndividualInterdisciplinary EducationK-Series Research Career ProgramsLearningLinkMentorsNCI Scholars ProgramPathway interactionsPhysiciansPreventive InterventionScientistTalentsTherapeutic InterventionTrainingTraining ProgramsTranslational Researchbasecareercareer developmentdigitalexperiencehealth disparityinnovationnext generationnovel diagnosticsprogramsskillstranslational scientist
项目摘要
Contact PD/PI: Murphy, Timothy F Inst-Career-Dev-001 (493)
KL2 Mentored Career Development Award. The CTSA-Linked KL2 mentored career development award
program (KL2 program) will strive to engage talented and motivated scholars to join the clinical and translational
science workforce with the goal of developing new diagnostic, preventive, and therapeutic interventions for
diseases, with an emphasis on addressing health disparities. The KL2 program has stimulated clinical and
translational research across the Buffalo Translational Consortium (BTC) by attracting, mentoring, training and
engaging scholars with diverse cultural, ethnic, racial and professional backgrounds and across scientific
disciplines (i.e. RN-PhDs, PharmDs, PhDs, MDs, and/or DDS-PhDs). These scholars receive an
interprofessional and interdisciplinary education where they learn with, about, and from each other, enabling
effective collaboration and discoveries in clinical and translational research. In the proposed funding period, the
KL2 program will train at least four junior faculty physician scientist scholars by supporting them for two years
on their path to independence, with the option of receiving an additional third year of institutional funding upon
completion of the program curriculum and objective evaluation of scholarly accomplishments. The program is
complemented by and integrated with the institutionally-funded BTC scholars program, allowing us to train five
(three in years 1-3; two in years 3-5) additional scholars under the same terms during the next funding period.
Integration of all scholars’ activities under our well-established mentoring and training program brings together
a critical mass of diverse professional experiences and talent benefiting all involved. The KL2 program has three
specific aims towards these goals are: 1) attract skilled and motivated early career clinical and translational
investigators from a broad range of health science disciplines, including individuals underrepresented in health
science; 2) provide comprehensive tailored support to mentor and train the scholars to promote pathways to
independence; and 3) engage scholars, facilitate interactions and enhance communications with the community
to raise awareness and accelerate solutions for health disparities. Innovations in our KL2 program include the
awarding of digital badges followed by micro-credentials, which are competency-based documentation of training
in specific areas; inclusion of community agency advisors and partners on scholars’ mentoring teams, aligning
with our goal to address health disparities in our community; and extensive partnering with other CTSA hubs.
The program will mentor, train and develop KL2 scholars’ professional skills and facilitate a seamless transition
to their next career level in the clinical and translational workforce. The overall goal of this KL2 program is to
develop the next generation of 21st century leaders whose backgrounds mirror the diversity of our community to
enhance excellence in clinical and translational research, locally and across the nation.
联系PD/PI:Murphy,Timothy F Inst-Career-Dev-001(493)
KL2指导职业发展奖。与CTSA相关的KL2指导职业发展奖
计划(KL2计划)将努力参与和成熟的学者加入临床和翻译
科学劳动力的目的是为开发新的诊断,预防和治疗干预措施
疾病,重点是解决健康差异。 KL2计划刺激了临床和
通过吸引,心理,培训和
与文化,种族,种族和专业背景以及跨科学的学者一起吸引学者
学科(即RN-PHD,PharmDS,Phds,MDS和/或DDS-PHD)。这些学者收到
跨专业和跨学科的教育,他们与他们一起学习,彼此学习
有效的临床和翻译研究中的合作和发现。在拟议的资金期间,
KL2计划将通过支持两年
在他们的独立之路上,可以选择获得额外的机构资金的第三年
完成课程课程和科学成就的客观评估。该程序是
由由机构资助的BTC学者计划完成并集成在一起,使我们能够培训五个
(1 - 3年中的三个;在第3-5年中,有两个)在下一个资金期内,在相同条款下的其他学者。
在我们建立的精神和培训计划下,所有学者活动的整合汇集
大量的潜水员专业经验和人才受益于所有参与。 KL2程序有三个
针对这些目标的具体目的是:1)吸引熟练和成熟的早期职业临床和翻译
来自众多健康科学学科的调查人员,包括健康不足的人
科学; 2)为心理和训练学者提供全面的量身定制支持,以促进通往的途径
独立; 3)参与学者,促进互动并增强与社区的沟通
提高认识并加速解决方案的健康差异。我们的KL2计划中的创新包括
授予数字徽章,然后是微观奖励,这是基于能力的培训文档
在特定领域;包括学者心理团队的社区代理顾问和合作伙伴
我们的目标是解决社区中的健康分配;并与其他CTSA枢纽合作。
该计划将指导,培训和发展KL2学者的专业技能,并促进无缝过渡
在临床和翻译员工中的下一个职业水平。这个KL2程序的总体目标是
发展下一代21世纪的领导者,其背景反映了我们社区的多样性
在本地和全国各地增强临床和翻译研究的卓越。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margarita L Dubocovich其他文献
Margarita L Dubocovich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margarita L Dubocovich', 18)}}的其他基金
Initiative for Maximizing Student Development at University at Buffalo
布法罗大学最大化学生发展倡议
- 批准号:
10361079 - 财政年份:2022
- 资助金额:
$ 44.74万 - 项目类别:
Mentoring For Success: Teaching Faculty Fundamental Skills For Attracting, Admitting and Developing Students
成功指导:教授教师吸引、录取和培养学生的基本技能
- 批准号:
10606074 - 财政年份:2022
- 资助金额:
$ 44.74万 - 项目类别:
Initiative for Maximizing Student Development at University at Buffalo
布法罗大学最大化学生发展倡议
- 批准号:
10551345 - 财政年份:2022
- 资助金额:
$ 44.74万 - 项目类别:
Buffalo Clinical and Translational Research Center
布法罗临床和转化研究中心
- 批准号:
9260958 - 财政年份:2015
- 资助金额:
$ 44.74万 - 项目类别:
Buffalo Clinical and Translational Research Center
布法罗临床和转化研究中心
- 批准号:
9125879 - 财政年份:2015
- 资助金额:
$ 44.74万 - 项目类别:
Environmental Circadian Disruptors Increase Diabetes and Metabolic Disorders Risk
环境昼夜节律干扰物会增加糖尿病和代谢紊乱的风险
- 批准号:
8875686 - 财政年份:2014
- 资助金额:
$ 44.74万 - 项目类别:
Environmental Circadian Disruptors Increase Diabetes and Metabolic Disorders Risk
环境昼夜节律干扰物会增加糖尿病和代谢紊乱的风险
- 批准号:
9145844 - 财政年份:2014
- 资助金额:
$ 44.74万 - 项目类别:
Environmental Circadian Disruptors Increase Diabetes and Metabolic Disorders Risk
环境昼夜节律干扰物会增加糖尿病和代谢紊乱的风险
- 批准号:
8772071 - 财政年份:2014
- 资助金额:
$ 44.74万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 44.74万 - 项目类别:
Assessing Native Hawaiian and Pacific Islander Maternal Outcomes and Health Care Experiences
评估夏威夷原住民和太平洋岛民的产妇结局和医疗保健体验
- 批准号:
10644888 - 财政年份:2023
- 资助金额:
$ 44.74万 - 项目类别:
HEAR-HEARTFELT (Identifying the risk of Hospitalizations or Emergency depARtment visits for patients with HEART Failure in managed long-term care through vErbaL communicaTion)
倾听心声(通过口头交流确定长期管理护理中的心力衰竭患者住院或急诊就诊的风险)
- 批准号:
10723292 - 财政年份:2023
- 资助金额:
$ 44.74万 - 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
- 批准号:
10724304 - 财政年份:2023
- 资助金额:
$ 44.74万 - 项目类别:
Implementing Evidence-Based Treatment for Common Mental Disorders in HIV Clinics in Ukraine
在乌克兰艾滋病毒诊所对常见精神疾病实施循证治疗
- 批准号:
10762576 - 财政年份:2023
- 资助金额:
$ 44.74万 - 项目类别: